Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post- TIPSS refractory hepatic encephalopathy

Kochar, N.; Tripathi, D.; Ireland, H.; Redhead, D. N.; Hayes, P. C.
November 2006
Gut;Nov2006, Vol. 55 Issue 11, p1617
Academic Journal
Background: Post-transjugular intrahepatic portosystemic stent shunt (TIPSS) hepatic encephalopathy (HE) can occur in up to one third of patients. In 5%, this can be refractory to optimal medical treatment and may require shunt modification. The efficacy of shunt modification has been poorly studied. Aims: To evaluate the efficacy of and natural history following TIPSS modification for treatment of refractory HE. Methods: From a dedicated database, we selected and further studied patients who had TIPSS modification for refractory HE. Results: Over a 14 year period, of 733 TIPSS insertions, 211(29%) patients developed HE post-TIPSS. In 38 patients, shunt modification (reduction (n = 9) and occlusion (n = 29)) was performed for refractory HE. Indications for TIPSS were: variceal bleeding (n=32), refractory ascites (n=5), and other (n= 1). Child's grades A, B, and C were noted in 11%, 47%, and 42% of cases, respectively. HE improved in 58% of patients and remained unchanged or worsened in 42%, with similar results for occlusions and reductions. Following shunt modification, variceal bleeding recurred in three patients and ascites in three. Twenty five patients have died (liver related in 15) at a median duration of 10.2 months. Three patients died due to procedure related complications following shunt occlusions (mesenteric infarction (n = 2) and septicaemia (n = 1)). Median survival of patients whose HE did not improve following shunt modification was 79 days compared with 278 days in patients whose did (p<0.05). No variables independently predicted response to shunt modification. Conclusions: TIPSS modification is a useful option for patients with refractory HE following TIPSS insertion. Due to the significant risk of iatrogenic complications with shunt occlusions, shunt reduction is a safer and preferred option.


Related Articles

  • Current Management of Portal Hypertension Wright, Andrew S.; Rikkers, Layton F. // Journal of Gastrointestinal Surgery;Sep2005, Vol. 9 Issue 7, p992 

    Portal hypertension can lead to life-threatening hemorrhage, ascites, and encephalopathy. This paper reviews the pathophysiology and multidisciplinary management of portal hypertension and its complications, including the indications for and techniques of the various surgical shunts. Variceal...

  • Outcome of 100 Patients after Transjugular Intrahepatic Portosystemic Shunt for Variceal Hemorrhage. Sahagun, Geronimo; Benner, Kent G.; Saxon, Richard; Barton, Robert E.; Rabkin, John; Keller, Frederick S.; Rosch, Josef // American Journal of Gastroenterology;Sep1997, Vol. 92 Issue 9, p1444 

    Objectives: One hundred consecutive patients with recurrent or refractory acute variceal hemorrhage treated with a transjugular intrahepatic portosystemic shunt (TIPS) from June 1990 to June 1993 at Oregon Health Sciences University or the Portland Veterans Affairs Medical Center were evaluated...

  • LARGE VOLUME PARACENTESIS -- ALL AT ONCE? Richards, Bob; McCallum, Richard; Johnson, David A.; Cattau Jr., Edward L. // American Journal of Gastroenterology;Aug1990, Vol. 85 Issue 8, p1039 

    Thirty-eight cirrhotic patients with tense ascites were treated with total paracentesis plus intravenous albumin (6-8 g/L ascites removed). No change from baseline values were noted in liver function tests, renal function tests, plasma volume, plasma renin activity, plasma aldosterone activity,...

  • Inflammation: a way to understanding the evolution of portal hypertension. Aller, María-Angeles; Arias, Jorge-Luis; Cruz, Arturo; Arias, Jaime // Theoretical Biology & Medical Modelling;2007, Vol. 4, p44 

    Background: Portal hypertension is a clinical syndrome that manifests as ascites, portosystemic encephalopathy and variceal hemorrhage, and these alterations often lead to death. Hypothesis: Splanchnic and/or systemic responses to portal hypertension could have pathophysiological mechanisms...

  • Hepatic encephalopathy due to intrahepatic portosystemic venous shunt successfully treated by balloon occluded retrograde transvenous embolization with GDCs. Yamagami, Takuji; Yoshimatsu, Rika; Miura, Hiroshi; Hasebe, Terumitsu; Koide, Kazuma // Acta Radiologica Short Reports;Nov2012, Vol. 1 Issue 10, Special section p1 

    We report a 65-year-old man with hepatic encephalopathy due to an intrahepatic portosystemic venous shunt that was successfully occluded by balloon occluded retrograde transvenous embolization with Guglielmi and interlocking detachable coils as performed percutaneously.

  • 'Predicting Hospital Mortality in Cirrhotic Patients: Comparison of Child-Pugh and Acute Physiology, Age and Chronic Health Evaluation (APACHE III) Scoring Systems. Butt, Arshad K.; Khan, Anwaar A.; Alam, Altaf; Shah, S. Waqar H.; Shafqat, Farzana; Naqvi, Altaf Baqir // American Journal of Gastroenterology;Dec1998, Vol. 93 Issue 12, p2469 

    Objective: The severity of hepatic abnormalities and extent of dysfunction of other organ systems influences prognosis for cirrhosis. The Child-Pugh system has been used to classify cirrhotic patients into good, intermediate, or poor risk categories in evaluation and therapy. Disregard for...


    The article presents a case of transjugular intrahepatic portosystemic shunting (TIPSS). Since 1988, TIPSS has been widely promoted as a treatment for uncontrolled variceal bleeding and refractory ascites. The study presents an 11 year review of TIPSS in a tertiary referral centre. The aim of...

  • Clinical Manifestations of Portal Hypertension. Al-Busafi, Said A.; McNabb-Baltar, Julia; Farag, Amanda; Hilzenrat, Nir // International Journal of Hepatology;2012, p1 

    The portal hypertension is responsible for many of the manifestations of liver cirrhosis. Some of these complications are the direct consequences of portal hypertension, such as gastrointestinal bleeding from ruptured gastroesophageal varices and from portal hypertensive gastropathy and...

  • Protective Value of TIPS Against the Development of Hydrothorax/Ascites and Upper Gastrointestinal Bleeding after Balloon-Occluded Retrograde Transvenous Obliteration (BRTO). Saad, Wael EA; Wagner, Cynthia (Cindy); Lippert, Allison; Al-Osaimi, Abdullah; Davies, Mark G; Matsumoto, Alan H; Angle, John (Fritz); Caldwell, Stephen // American Journal of Gastroenterology;Oct2013, Vol. 108 Issue 10, p1612 

    OBJECTIVES:The objective of this study was to evaluate the incidence of post-balloon-occluded retrograde transvenous obliteration (BRTO) ascites/hepatic hydrothorax and rebleeding rate (variceal and non-variceal) in the presence and absence of a transjugular intrahepatic portosystemic shunt...


Read the Article


Sign out of this library

Other Topics